stars 1 stars 2 stars 3

OCMS Bio® is a Research Tools Company. Our proprietary technology On-Cell mAb Screening (OCMS®), greatly speeds antibody discovery. OCMS® methods transform mAb discovery from patient-derived antibodies, transgenic mouse models, and Artificial Intelligence (AI) antibody engineering.

OCMS Bio Questions

Paul Halpern is the Chairman and CEO of OCMS Bio.

6 people are employed at OCMS Bio.

OCMS Bio is based in King of Prussia, Pennsylvania.

Top OCMS Bio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users